1. Home
  2. AUID vs PASG Comparison

AUID vs PASG Comparison

Compare AUID & PASG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo authID Inc.

AUID

authID Inc.

HOLD

Current Price

$1.36

Market Cap

23.2M

Sector

Technology

ML Signal

HOLD

PASG

Passage Bio Inc.

HOLD

Current Price

$7.02

Market Cap

26.0M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
AUID
PASG
Founded
2009
2017
Country
United States
United States
Employees
N/A
27
Industry
Computer Software: Prepackaged Software
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
23.2M
26.0M
IPO Year
2014
2020

Fundamental Metrics

Financial Performance
Metric
AUID
PASG
Price
$1.36
$7.02
Analyst Decision
Strong Buy
Analyst Count
0
4
Target Price
N/A
$23.50
AVG Volume (30 Days)
257.5K
31.7K
Earning Date
05-12-2026
03-03-2026
Dividend Yield
N/A
N/A
EPS Growth
60.00
N/A
EPS
N/A
N/A
Revenue
$886,485.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
365.86
N/A
52 Week Low
$0.84
$0.28
52 Week High
$9.44
$20.00

Technical Indicators

Market Signals
Indicator
AUID
PASG
Relative Strength Index (RSI) 41.27 38.17
Support Level $1.19 $6.71
Resistance Level $1.38 $7.72
Average True Range (ATR) 0.11 0.70
MACD -0.02 -0.01
Stochastic Oscillator 5.59 18.83

Price Performance

Historical Comparison
AUID
PASG

About AUID authID Inc.

AuthID Inc is a company engaged in ensuring cyber-savvy enterprises Know Who's Behind the Device, for every customer or employee login and transaction. Through its easy-to-integrate, patented, biometric identity platform, authID quickly and accurately verifies a user's identity, eliminating any assumption of who is behind a device and preventing cybercriminals from taking over accounts. authID combines digital onboarding, biometric password less authentication and account recovery, with a fast, accurate, user-friendly experience-delivering identity verification.

About PASG Passage Bio Inc.

Passage Bio Inc is a clinical-stage genetic medicines company focused on improving the lives of patients with neurodegenerative diseases. Their primary focus is the development and advancement of cutting-edge, one-time gene therapies designed to target critical underlying pathologies in these conditions. The Company operates in a single reportable segment, developing and advancing genetic medicines designed to target the critical underlying pathology of neurodegenerative diseases. The pipeline having PBFT02.

Share on Social Networks: